

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.66798406 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.66798406 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.36364059 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.36364059 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.87939604 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.49691602 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 6.19487740 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 6.19487740 |
| 9 | tryptophan catabolic process (GO:0006569) | 6.19487740 |
| 10 | kynurenine metabolic process (GO:0070189) | 6.06769501 |
| 11 | exogenous drug catabolic process (GO:0042738) | 5.96444050 |
| 12 | bile acid biosynthetic process (GO:0006699) | 5.95695366 |
| 13 | tryptophan metabolic process (GO:0006568) | 5.82649563 |
| 14 | glyoxylate metabolic process (GO:0046487) | 5.79960354 |
| 15 | urea cycle (GO:0000050) | 5.76351377 |
| 16 | urea metabolic process (GO:0019627) | 5.76351377 |
| 17 | high-density lipoprotein particle remodeling (GO:0034375) | 5.67950490 |
| 18 | negative regulation of fibrinolysis (GO:0051918) | 5.62740379 |
| 19 | alpha-linolenic acid metabolic process (GO:0036109) | 5.58406903 |
| 20 | regulation of fibrinolysis (GO:0051917) | 5.41669440 |
| 21 | cysteine metabolic process (GO:0006534) | 5.41605630 |
| 22 | sulfur amino acid catabolic process (GO:0000098) | 5.39615036 |
| 23 | protein carboxylation (GO:0018214) | 5.36814580 |
| 24 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.36814580 |
| 25 | nitrogen cycle metabolic process (GO:0071941) | 5.30115199 |
| 26 | serine family amino acid catabolic process (GO:0009071) | 5.26384829 |
| 27 | regulation of protein activation cascade (GO:2000257) | 5.25176573 |
| 28 | intestinal cholesterol absorption (GO:0030299) | 5.24567278 |
| 29 | complement activation, alternative pathway (GO:0006957) | 5.23235798 |
| 30 | bile acid metabolic process (GO:0008206) | 5.10955640 |
| 31 | epoxygenase P450 pathway (GO:0019373) | 5.07023624 |
| 32 | aromatic amino acid family metabolic process (GO:0009072) | 5.01999744 |
| 33 | regulation of cholesterol esterification (GO:0010872) | 4.97366925 |
| 34 | reverse cholesterol transport (GO:0043691) | 4.95343447 |
| 35 | regulation of triglyceride catabolic process (GO:0010896) | 4.92817374 |
| 36 | regulation of complement activation (GO:0030449) | 4.89239064 |
| 37 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.86059404 |
| 38 | tyrosine metabolic process (GO:0006570) | 4.85138224 |
| 39 | homocysteine metabolic process (GO:0050667) | 4.84308960 |
| 40 | protein-lipid complex remodeling (GO:0034368) | 4.83749037 |
| 41 | macromolecular complex remodeling (GO:0034367) | 4.83749037 |
| 42 | plasma lipoprotein particle remodeling (GO:0034369) | 4.83749037 |
| 43 | acylglycerol homeostasis (GO:0055090) | 4.70702900 |
| 44 | triglyceride homeostasis (GO:0070328) | 4.70702900 |
| 45 | alpha-amino acid catabolic process (GO:1901606) | 4.70273263 |
| 46 | negative regulation of cholesterol transport (GO:0032375) | 4.67847577 |
| 47 | negative regulation of sterol transport (GO:0032372) | 4.67847577 |
| 48 | phospholipid efflux (GO:0033700) | 4.67458745 |
| 49 | amino-acid betaine metabolic process (GO:0006577) | 4.66396141 |
| 50 | lysine catabolic process (GO:0006554) | 4.59188504 |
| 51 | lysine metabolic process (GO:0006553) | 4.59188504 |
| 52 | cellular ketone body metabolic process (GO:0046950) | 4.56926857 |
| 53 | glycine metabolic process (GO:0006544) | 4.54541724 |
| 54 | plasma lipoprotein particle clearance (GO:0034381) | 4.41656249 |
| 55 | imidazole-containing compound metabolic process (GO:0052803) | 4.41487664 |
| 56 | bile acid and bile salt transport (GO:0015721) | 4.40940294 |
| 57 | coenzyme catabolic process (GO:0009109) | 4.40601148 |
| 58 | indolalkylamine metabolic process (GO:0006586) | 4.38617310 |
| 59 | cellular amino acid catabolic process (GO:0009063) | 4.32597401 |
| 60 | cellular biogenic amine catabolic process (GO:0042402) | 4.29760381 |
| 61 | amine catabolic process (GO:0009310) | 4.29760381 |
| 62 | glutamate metabolic process (GO:0006536) | 4.28742999 |
| 63 | cholesterol efflux (GO:0033344) | 4.27535285 |
| 64 | omega-hydroxylase P450 pathway (GO:0097267) | 4.27139256 |
| 65 | serine family amino acid metabolic process (GO:0009069) | 4.26582888 |
| 66 | cellular glucuronidation (GO:0052695) | 4.24132066 |
| 67 | benzene-containing compound metabolic process (GO:0042537) | 4.12270033 |
| 68 | serine family amino acid biosynthetic process (GO:0009070) | 4.11732232 |
| 69 | ethanol oxidation (GO:0006069) | 4.08282392 |
| 70 | cellular modified amino acid catabolic process (GO:0042219) | 4.07508787 |
| 71 | intestinal absorption (GO:0050892) | 4.06844226 |
| 72 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.04651353 |
| 73 | plasma lipoprotein particle assembly (GO:0034377) | 4.04276926 |
| 74 | drug metabolic process (GO:0017144) | 4.02774511 |
| 75 | aldehyde catabolic process (GO:0046185) | 4.02665553 |
| 76 | low-density lipoprotein particle remodeling (GO:0034374) | 4.01466752 |
| 77 | fibrinolysis (GO:0042730) | 3.99219082 |
| 78 | flavonoid metabolic process (GO:0009812) | 3.98896099 |
| 79 | ketone body metabolic process (GO:1902224) | 3.95603126 |
| 80 | oxidative demethylation (GO:0070989) | 3.92836198 |
| 81 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.91737127 |
| 82 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.91737127 |
| 83 | drug catabolic process (GO:0042737) | 3.90441649 |
| 84 | blood coagulation, intrinsic pathway (GO:0007597) | 3.86072490 |
| 85 | cofactor catabolic process (GO:0051187) | 3.81781479 |
| 86 | regulation of bile acid biosynthetic process (GO:0070857) | 3.81368461 |
| 87 | negative regulation of lipase activity (GO:0060192) | 3.78337804 |
| 88 | organic acid catabolic process (GO:0016054) | 3.78015123 |
| 89 | carboxylic acid catabolic process (GO:0046395) | 3.78015123 |
| 90 | cholesterol homeostasis (GO:0042632) | 3.77855739 |
| 91 | protein-lipid complex subunit organization (GO:0071825) | 3.77763118 |
| 92 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.76937552 |
| 93 | positive regulation of lipid catabolic process (GO:0050996) | 3.76101143 |
| 94 | uronic acid metabolic process (GO:0006063) | 3.75759522 |
| 95 | glucuronate metabolic process (GO:0019585) | 3.75759522 |
| 96 | complement activation, classical pathway (GO:0006958) | 3.73371745 |
| 97 | sterol homeostasis (GO:0055092) | 3.71698889 |
| 98 | phospholipid homeostasis (GO:0055091) | 3.69723301 |
| 99 | short-chain fatty acid metabolic process (GO:0046459) | 3.69338461 |
| 100 | complement activation (GO:0006956) | 3.68523747 |
| 101 | protein activation cascade (GO:0072376) | 3.68331261 |
| 102 | regulation of cholesterol homeostasis (GO:2000188) | 3.67190905 |
| 103 | plasma lipoprotein particle organization (GO:0071827) | 3.66829475 |
| 104 | * arginine metabolic process (GO:0006525) | 3.66081204 |
| 105 | acetyl-CoA metabolic process (GO:0006084) | 3.63565649 |
| 106 | NAD biosynthetic process (GO:0009435) | 3.62826954 |
| 107 | cytolysis (GO:0019835) | 3.62795846 |
| 108 | S-adenosylmethionine metabolic process (GO:0046500) | 3.62494489 |
| 109 | protein-lipid complex assembly (GO:0065005) | 3.61671531 |
| 110 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.58365229 |
| 111 | drug transmembrane transport (GO:0006855) | 3.56764603 |
| 112 | regulation of plasminogen activation (GO:0010755) | 3.53921472 |
| 113 | negative regulation of protein activation cascade (GO:2000258) | 3.53326721 |
| 114 | ethanol metabolic process (GO:0006067) | 3.31895732 |
| 115 | lipoprotein metabolic process (GO:0042157) | 3.30263291 |
| 116 | regulation of humoral immune response (GO:0002920) | 3.16095159 |
| 117 | oxaloacetate metabolic process (GO:0006107) | 3.12730794 |
| 118 | proline metabolic process (GO:0006560) | 3.12575023 |
| 119 | acute-phase response (GO:0006953) | 3.12274718 |
| 120 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.11412239 |
| 121 | negative regulation of hemostasis (GO:1900047) | 3.02281313 |
| 122 | negative regulation of blood coagulation (GO:0030195) | 3.02281313 |
| 123 | peptidyl-glutamic acid modification (GO:0018200) | 3.01093450 |
| 124 | L-fucose metabolic process (GO:0042354) | 3.01077623 |
| 125 | L-fucose catabolic process (GO:0042355) | 3.01077623 |
| 126 | fucose catabolic process (GO:0019317) | 3.01077623 |
| 127 | cholesterol transport (GO:0030301) | 2.99296846 |
| 128 | sterol transport (GO:0015918) | 2.99296846 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.45886446 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.27126723 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.08962010 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.53185698 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.33900322 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.20057148 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.90486169 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.06679153 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.02759970 |
| 10 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.10220805 |
| 11 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.51277197 |
| 12 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.40212196 |
| 13 | VDR_22108803_ChIP-Seq_LS180_Human | 2.37354199 |
| 14 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.34593103 |
| 15 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.13516682 |
| 16 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.09924658 |
| 17 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.03895846 |
| 18 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.01796071 |
| 19 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 12.0854075 |
| 20 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.99649205 |
| 21 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.98692984 |
| 22 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.88666295 |
| 23 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.76273741 |
| 24 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.58157074 |
| 25 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.56973019 |
| 26 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.54996540 |
| 27 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.49612537 |
| 28 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.47876722 |
| 29 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.47836336 |
| 30 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.46159481 |
| 31 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.42029036 |
| 32 | GATA1_22025678_ChIP-Seq_K562_Human | 1.39243012 |
| 33 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.37236022 |
| 34 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.37236022 |
| 35 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.35646846 |
| 36 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.34392575 |
| 37 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.31970210 |
| 38 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.31659444 |
| 39 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.29855715 |
| 40 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.28178549 |
| 41 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.25514627 |
| 42 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.25029699 |
| 43 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.24439339 |
| 44 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.23311298 |
| 45 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.23058402 |
| 46 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.22725488 |
| 47 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.22725488 |
| 48 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.21163693 |
| 49 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.16876221 |
| 50 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.16869303 |
| 51 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.16847805 |
| 52 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.14620988 |
| 53 | * ERA_21632823_ChIP-Seq_H3396_Human | 1.13324055 |
| 54 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.13106661 |
| 55 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.11735577 |
| 56 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.11563838 |
| 57 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.10404416 |
| 58 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.09535472 |
| 59 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.07047852 |
| 60 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.06783124 |
| 61 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.06411320 |
| 62 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.04092720 |
| 63 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.03836225 |
| 64 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.03369398 |
| 65 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.02859047 |
| 66 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.99370920 |
| 67 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.98813758 |
| 68 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.97653402 |
| 69 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.97587045 |
| 70 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.97380222 |
| 71 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.96625460 |
| 72 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.96028611 |
| 73 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.95975792 |
| 74 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.94950641 |
| 75 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.94038424 |
| 76 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.93576810 |
| 77 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.92436935 |
| 78 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90143856 |
| 79 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.90092214 |
| 80 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.89082925 |
| 81 | GATA3_26560356_Chip-Seq_TH2_Human | 0.88632612 |
| 82 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.85897774 |
| 83 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.85860217 |
| 84 | STAT3_23295773_ChIP-Seq_U87_Human | 0.85821074 |
| 85 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.85566224 |
| 86 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.84847744 |
| 87 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.84327798 |
| 88 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.84257122 |
| 89 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.84257122 |
| 90 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.83946219 |
| 91 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.82974422 |
| 92 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.82818220 |
| 93 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.82733497 |
| 94 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.82342195 |
| 95 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.82104175 |
| 96 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.81109060 |
| 97 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.80664976 |
| 98 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.80213407 |
| 99 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.79112651 |
| 100 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.78560063 |
| 101 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.76071048 |
| 102 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.73898137 |
| 103 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.70749152 |
| 104 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.69262572 |
| 105 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.68243146 |
| 106 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.66400815 |
| 107 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.64991897 |
| 108 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.64888639 |
| 109 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.64868253 |
| 110 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.64395944 |
| 111 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.64003079 |
| 112 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.63305778 |
| 113 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.62244850 |
| 114 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.60765884 |
| 115 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.60638034 |
| 116 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.60160616 |
| 117 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.58739408 |
| 118 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.58067382 |
| 119 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.57840010 |
| 120 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.57840010 |
| 121 | AR_20517297_ChIP-Seq_VCAP_Human | 0.52990020 |
| 122 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.52165883 |
| 123 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.52079915 |
| 124 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.52038455 |
| 125 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.50632047 |
| 126 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.50582912 |
| 127 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.50133160 |
| 128 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.49864001 |
| 129 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.49597332 |
| 130 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.48798638 |
| 131 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.48486092 |
| 132 | CBP_21632823_ChIP-Seq_H3396_Human | 0.47827456 |
| 133 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.46923234 |
| 134 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.46374748 |
| 135 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.44454562 |
| 136 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.44448198 |
| 137 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.44301253 |
| 138 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.42487337 |
| 139 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.41876264 |
| 140 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.41395396 |
| 141 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.39509913 |
| 142 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.39193023 |
| 143 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.39141486 |
| 144 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.39032303 |
| 145 | GATA1_19941826_ChIP-Seq_K562_Human | 0.38663158 |
| 146 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.38233061 |
| 147 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.38058943 |
| 148 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.37025323 |
| 149 | GATA2_19941826_ChIP-Seq_K562_Human | 0.36791370 |
| 150 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.36512719 |
| 151 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.36427143 |
| 152 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.36193369 |
| 153 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.35855403 |
| 154 | NCOR_22424771_ChIP-Seq_293T_Human | 0.35388709 |
| 155 | * MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.35269732 |
| 156 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.35183306 |
| 157 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.34818595 |
| 158 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.34545572 |
| 159 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.34473346 |
| 160 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.33121601 |
| 161 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.32960586 |
| 162 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.32741598 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.36392612 |
| 2 | MP0005360_urolithiasis | 7.59055845 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.46493804 |
| 4 | MP0005365_abnormal_bile_salt | 6.18997334 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.11929143 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.32549765 |
| 7 | MP0003252_abnormal_bile_duct | 3.90811463 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.60761500 |
| 9 | MP0009840_abnormal_foam_cell | 3.38990515 |
| 10 | MP0005083_abnormal_biliary_tract | 3.03727109 |
| 11 | MP0003195_calcinosis | 2.84974500 |
| 12 | MP0005332_abnormal_amino_acid | 2.79672485 |
| 13 | MP0003646_muscle_fatigue | 2.69934928 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.62168411 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.32838145 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.15946716 |
| 17 | MP0000609_abnormal_liver_physiology | 2.15901197 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 2.09702699 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 1.96756835 |
| 20 | MP0004145_abnormal_muscle_electrophysio | 1.91727416 |
| 21 | MP0003868_abnormal_feces_composition | 1.90938302 |
| 22 | MP0004043_abnormal_pH_regulation | 1.87052817 |
| 23 | MP0005319_abnormal_enzyme/_coenzyme | 1.83154290 |
| 24 | MP0001764_abnormal_homeostasis | 1.71428551 |
| 25 | MP0009697_abnormal_copulation | 1.65307274 |
| 26 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.56999081 |
| 27 | MP0005451_abnormal_body_composition | 1.56828011 |
| 28 | MP0003011_delayed_dark_adaptation | 1.39569843 |
| 29 | MP0003122_maternal_imprinting | 1.38308564 |
| 30 | MP0003186_abnormal_redox_activity | 1.28855775 |
| 31 | MP0003656_abnormal_erythrocyte_physiolo | 1.28264195 |
| 32 | MP0009643_abnormal_urine_homeostasis | 1.23571988 |
| 33 | MP0004147_increased_porphyrin_level | 1.20605030 |
| 34 | MP0000598_abnormal_liver_morphology | 1.16816960 |
| 35 | MP0005551_abnormal_eye_electrophysiolog | 1.15641057 |
| 36 | MP0005647_abnormal_sex_gland | 1.13911894 |
| 37 | MP0003705_abnormal_hypodermis_morpholog | 1.12560881 |
| 38 | MP0001873_stomach_inflammation | 1.09061450 |
| 39 | MP0000604_amyloidosis | 1.07418545 |
| 40 | MP0003183_abnormal_peptide_metabolism | 1.07148255 |
| 41 | MP0009764_decreased_sensitivity_to | 1.03292217 |
| 42 | MP0009763_increased_sensitivity_to | 1.00414126 |
| 43 | MP0005167_abnormal_blood-brain_barrier | 0.99532799 |
| 44 | MP0002254_reproductive_system_inflammat | 0.99267428 |
| 45 | MP0005636_abnormal_mineral_homeostasis | 0.92416356 |
| 46 | MP0010368_abnormal_lymphatic_system | 0.90474990 |
| 47 | MP0009780_abnormal_chondrocyte_physiolo | 0.90063489 |
| 48 | MP0002638_abnormal_pupillary_reflex | 0.89022689 |
| 49 | MP0001986_abnormal_taste_sensitivity | 0.88356114 |
| 50 | MP0001765_abnormal_ion_homeostasis | 0.88006477 |
| 51 | MP0008469_abnormal_protein_level | 0.87428539 |
| 52 | MP0009642_abnormal_blood_homeostasis | 0.86967025 |
| 53 | MP0006036_abnormal_mitochondrial_physio | 0.86810608 |
| 54 | MP0005408_hypopigmentation | 0.85799818 |
| 55 | MP0004142_abnormal_muscle_tone | 0.81603716 |
| 56 | MP0005376_homeostasis/metabolism_phenot | 0.80370795 |
| 57 | MP0009333_abnormal_splenocyte_physiolog | 0.79482872 |
| 58 | MP0002876_abnormal_thyroid_physiology | 0.78636405 |
| 59 | MP0003879_abnormal_hair_cell | 0.77630901 |
| 60 | MP0005645_abnormal_hypothalamus_physiol | 0.77541346 |
| 61 | MP0002078_abnormal_glucose_homeostasis | 0.76732461 |
| 62 | MP0009765_abnormal_xenobiotic_induced | 0.76412875 |
| 63 | MP0005084_abnormal_gallbladder_morpholo | 0.75815709 |
| 64 | MP0002938_white_spotting | 0.72746115 |
| 65 | MP0003567_abnormal_fetal_cardiomyocyte | 0.72111870 |
| 66 | MP0005670_abnormal_white_adipose | 0.71878423 |
| 67 | MP0005410_abnormal_fertilization | 0.70191933 |
| 68 | MP0005220_abnormal_exocrine_pancreas | 0.70000754 |
| 69 | MP0002971_abnormal_brown_adipose | 0.69924173 |
| 70 | MP0005334_abnormal_fat_pad | 0.67490828 |
| 71 | MP0002089_abnormal_postnatal_growth/wei | 0.66349394 |
| 72 | MP0001661_extended_life_span | 0.66180929 |
| 73 | MP0009053_abnormal_anal_canal | 0.65833126 |
| 74 | MP0005266_abnormal_metabolism | 0.65616306 |
| 75 | MP0005535_abnormal_body_temperature | 0.65573937 |
| 76 | MP0002106_abnormal_muscle_physiology | 0.65411672 |
| 77 | MP0004130_abnormal_muscle_cell | 0.64697859 |
| 78 | MP0002102_abnormal_ear_morphology | 0.63820913 |
| 79 | MP0002693_abnormal_pancreas_physiology | 0.63581451 |
| 80 | MP0003690_abnormal_glial_cell | 0.63479433 |
| 81 | MP0000566_synostosis | 0.62365828 |
| 82 | MP0003329_amyloid_beta_deposits | 0.62183338 |
| 83 | MP0005379_endocrine/exocrine_gland_phen | 0.59875625 |
| 84 | MP0000639_abnormal_adrenal_gland | 0.59466571 |
| 85 | MP0006035_abnormal_mitochondrial_morpho | 0.59448732 |
| 86 | MP0001756_abnormal_urination | 0.59380147 |
| 87 | MP0002160_abnormal_reproductive_system | 0.57662104 |
| 88 | MP0000013_abnormal_adipose_tissue | 0.56708765 |
| 89 | MP0000685_abnormal_immune_system | 0.56105361 |
| 90 | MP0005448_abnormal_energy_balance | 0.55664661 |
| 91 | MP0005389_reproductive_system_phenotype | 0.55476076 |
| 92 | MP0003718_maternal_effect | 0.55016125 |
| 93 | MP0004742_abnormal_vestibular_system | 0.54753424 |
| 94 | MP0002822_catalepsy | 0.53213712 |
| 95 | MP0003136_yellow_coat_color | 0.51581879 |
| 96 | MP0005395_other_phenotype | 0.51255040 |
| 97 | MP0002163_abnormal_gland_morphology | 0.50618197 |
| 98 | MP0005646_abnormal_pituitary_gland | 0.50478433 |
| 99 | MP0005464_abnormal_platelet_physiology | 0.49942648 |
| 100 | MP0005369_muscle_phenotype | 0.48689451 |
| 101 | MP0002269_muscular_atrophy | 0.48456930 |
| 102 | MP0008877_abnormal_DNA_methylation | 0.47842405 |
| 103 | MP0001324_abnormal_eye_pigmentation | 0.47686569 |
| 104 | MP0002909_abnormal_adrenal_gland | 0.47556820 |
| 105 | MP0000371_diluted_coat_color | 0.47347464 |
| 106 | MP0003950_abnormal_plasma_membrane | 0.47088460 |
| 107 | MP0000538_abnormal_urinary_bladder | 0.45490755 |
| 108 | MP0003638_abnormal_response/metabolism_ | 0.45394615 |
| 109 | MP0001485_abnormal_pinna_reflex | 0.44984402 |
| 110 | MP0008874_decreased_physiological_sensi | 0.44425889 |
| 111 | MP0002136_abnormal_kidney_physiology | 0.44376572 |
| 112 | MP0004782_abnormal_surfactant_physiolog | 0.44202352 |
| 113 | MP0008873_increased_physiological_sensi | 0.43664570 |
| 114 | MP0008961_abnormal_basal_metabolism | 0.43643367 |
| 115 | MP0000372_irregular_coat_pigmentation | 0.42994558 |
| 116 | MP0003943_abnormal_hepatobiliary_system | 0.42932976 |
| 117 | MP0002928_abnormal_bile_duct | 0.42643078 |
| 118 | MP0008872_abnormal_physiological_respon | 0.41576141 |
| 119 | MP0001968_abnormal_touch/_nociception | 0.41250833 |
| 120 | MP0003953_abnormal_hormone_level | 0.40879084 |
| 121 | MP0002837_dystrophic_cardiac_calcinosis | 0.40424842 |
| 122 | MP0005248_abnormal_Harderian_gland | 0.39405416 |
| 123 | MP0003724_increased_susceptibility_to | 0.38736586 |
| 124 | MP0003436_decreased_susceptibility_to | 0.37621199 |
| 125 | MP0009672_abnormal_birth_weight | 0.37552213 |
| 126 | MP0005166_decreased_susceptibility_to | 0.37451571 |
| 127 | MP0003075_altered_response_to | 0.37240092 |
| 128 | MP0005666_abnormal_adipose_tissue | 0.35964816 |
| 129 | MP0004381_abnormal_hair_follicle | 0.35367964 |
| 130 | MP0006082_CNS_inflammation | 0.32630346 |
| 131 | MP0009115_abnormal_fat_cell | 0.32402582 |
| 132 | MP0002796_impaired_skin_barrier | 0.32377719 |
| 133 | MP0000579_abnormal_nail_morphology | 0.32225452 |
| 134 | MP0000249_abnormal_blood_vessel | 0.31476545 |
| 135 | MP0000230_abnormal_systemic_arterial | 0.31143162 |
| 136 | MP0001243_abnormal_dermal_layer | 0.30533228 |
| 137 | MP0004883_abnormal_blood_vessel | 0.30295160 |
| 138 | MP0002168_other_aberrant_phenotype | 0.29207535 |
| 139 | MP0002970_abnormal_white_adipose | 0.28816179 |
| 140 | MP0002132_abnormal_respiratory_system | 0.28701106 |
| 141 | MP0001853_heart_inflammation | 0.27401414 |
| 142 | MP0001845_abnormal_inflammatory_respons | 0.27259777 |
| 143 | MP0001881_abnormal_mammary_gland | 0.26821739 |
| 144 | MP0009384_cardiac_valve_regurgitation | 0.24656397 |
| 145 | MP0005164_abnormal_response_to | 0.22245606 |
| 146 | MP0002060_abnormal_skin_morphology | 0.22227411 |
| 147 | MP0005058_abnormal_lysosome_morphology | 0.21663164 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.52444524 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.38343046 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.27281457 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.74071508 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.51724646 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.47755177 |
| 7 | Xanthomatosis (HP:0000991) | 6.25730230 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.63144179 |
| 9 | Complement deficiency (HP:0004431) | 5.21037672 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.81635605 |
| 11 | Joint hemorrhage (HP:0005261) | 4.75996063 |
| 12 | Hyperammonemia (HP:0001987) | 4.68675266 |
| 13 | Hyperglycinemia (HP:0002154) | 4.57098459 |
| 14 | Epidermoid cyst (HP:0200040) | 4.41592012 |
| 15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.38959151 |
| 16 | Abnormality of the common coagulation pathway (HP:0010990) | 4.38096032 |
| 17 | Abnormality of methionine metabolism (HP:0010901) | 4.33328388 |
| 18 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.28597239 |
| 19 | Ketosis (HP:0001946) | 4.25466322 |
| 20 | Hypoalphalipoproteinemia (HP:0003233) | 4.19348618 |
| 21 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.15807513 |
| 22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.14855275 |
| 23 | Fat malabsorption (HP:0002630) | 4.09753956 |
| 24 | Hyperglycinuria (HP:0003108) | 4.02183587 |
| 25 | Abnormality of glycine metabolism (HP:0010895) | 4.00019306 |
| 26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.00019306 |
| 27 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.91776026 |
| 28 | Hypoglycemic coma (HP:0001325) | 3.87230681 |
| 29 | Abnormality of complement system (HP:0005339) | 3.80025280 |
| 30 | Conjugated hyperbilirubinemia (HP:0002908) | 3.72353619 |
| 31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.72284229 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.58334291 |
| 33 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.41954674 |
| 34 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.39909332 |
| 35 | Hyperbilirubinemia (HP:0002904) | 3.34638561 |
| 36 | Abnormality of serum amino acid levels (HP:0003112) | 3.19010431 |
| 37 | Delayed CNS myelination (HP:0002188) | 3.17152222 |
| 38 | Abnormality of nucleobase metabolism (HP:0010932) | 3.09002774 |
| 39 | Steatorrhea (HP:0002570) | 3.08511741 |
| 40 | Spontaneous abortion (HP:0005268) | 3.01531587 |
| 41 | Hepatocellular carcinoma (HP:0001402) | 2.99919241 |
| 42 | Ketoacidosis (HP:0001993) | 2.99155327 |
| 43 | Hypochromic microcytic anemia (HP:0004840) | 2.96126497 |
| 44 | Myocardial infarction (HP:0001658) | 2.90770607 |
| 45 | Metabolic acidosis (HP:0001942) | 2.81159211 |
| 46 | Muscle fiber inclusion bodies (HP:0100299) | 2.75833784 |
| 47 | Skin nodule (HP:0200036) | 2.71433005 |
| 48 | Lethargy (HP:0001254) | 2.69965500 |
| 49 | Abnormality of alanine metabolism (HP:0010916) | 2.69549736 |
| 50 | Hyperalaninemia (HP:0003348) | 2.69549736 |
| 51 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.69549736 |
| 52 | Bile duct proliferation (HP:0001408) | 2.69348445 |
| 53 | Abnormal biliary tract physiology (HP:0012439) | 2.69348445 |
| 54 | Facial shape deformation (HP:0011334) | 2.68304649 |
| 55 | Potter facies (HP:0002009) | 2.68304649 |
| 56 | Abnormality of purine metabolism (HP:0004352) | 2.67616148 |
| 57 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.66383034 |
| 58 | Dicarboxylic aciduria (HP:0003215) | 2.66383034 |
| 59 | Nemaline bodies (HP:0003798) | 2.66335288 |
| 60 | Systemic lupus erythematosus (HP:0002725) | 2.64371329 |
| 61 | Vascular calcification (HP:0004934) | 2.59376691 |
| 62 | Fair hair (HP:0002286) | 2.54747835 |
| 63 | Cerebral edema (HP:0002181) | 2.50466687 |
| 64 | Acanthocytosis (HP:0001927) | 2.49655658 |
| 65 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.46885730 |
| 66 | Gout (HP:0001997) | 2.46471074 |
| 67 | Spastic diplegia (HP:0001264) | 2.45561172 |
| 68 | Hypoglycemic seizures (HP:0002173) | 2.45195591 |
| 69 | Abnormal gallbladder morphology (HP:0012437) | 2.44386017 |
| 70 | Arthropathy (HP:0003040) | 2.42126031 |
| 71 | Glomerulonephritis (HP:0000099) | 2.39556096 |
| 72 | Cholelithiasis (HP:0001081) | 2.39385087 |
| 73 | Irritability (HP:0000737) | 2.38034999 |
| 74 | Mitral stenosis (HP:0001718) | 2.37931557 |
| 75 | Malnutrition (HP:0004395) | 2.36558399 |
| 76 | Neonatal onset (HP:0003623) | 2.34682516 |
| 77 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.33851701 |
| 78 | Abnormal urine output (HP:0012590) | 2.33102565 |
| 79 | Abnormality of the renal cortex (HP:0011035) | 2.32025120 |
| 80 | Abnormal gallbladder physiology (HP:0012438) | 2.30867492 |
| 81 | Cholecystitis (HP:0001082) | 2.30867492 |
| 82 | Pigmentary retinal degeneration (HP:0001146) | 2.30735471 |
| 83 | Cardiovascular calcification (HP:0011915) | 2.29443955 |
| 84 | Amyloidosis (HP:0011034) | 2.26104275 |
| 85 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.24262590 |
| 86 | Hypothermia (HP:0002045) | 2.21630128 |
| 87 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.21375738 |
| 88 | Gingival bleeding (HP:0000225) | 2.19396499 |
| 89 | Esophageal varix (HP:0002040) | 2.16793630 |
| 90 | Brushfield spots (HP:0001088) | 2.15977020 |
| 91 | Menorrhagia (HP:0000132) | 2.15219020 |
| 92 | Pancreatitis (HP:0001733) | 2.14981665 |
| 93 | Sensorimotor neuropathy (HP:0007141) | 2.13329908 |
| 94 | Late onset (HP:0003584) | 2.12308998 |
| 95 | Vomiting (HP:0002013) | 2.11627849 |
| 96 | Enlarged kidneys (HP:0000105) | 2.07216312 |
| 97 | Generalized aminoaciduria (HP:0002909) | 2.05749574 |
| 98 | Hypomagnesemia (HP:0002917) | 2.05658353 |
| 99 | Thrombophlebitis (HP:0004418) | 2.05432319 |
| 100 | Opisthotonus (HP:0002179) | 2.05170072 |
| 101 | Calf muscle hypertrophy (HP:0008981) | 2.02852201 |
| 102 | Poikilocytosis (HP:0004447) | 2.02686651 |
| 103 | Abnormality of the gallbladder (HP:0005264) | 1.98953194 |
| 104 | Abnormality of renal excretion (HP:0011036) | 1.98741786 |
| 105 | Hemorrhage of the eye (HP:0011885) | 1.98009271 |
| 106 | Metabolic alkalosis (HP:0200114) | 1.97853951 |
| 107 | Nephritis (HP:0000123) | 1.97070350 |
| 108 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.96450267 |
| 109 | Pancreatic cysts (HP:0001737) | 1.95837874 |
| 110 | Abnormal drinking behavior (HP:0030082) | 1.95134961 |
| 111 | Polydipsia (HP:0001959) | 1.95134961 |
| 112 | Hyperphosphaturia (HP:0003109) | 1.95124582 |
| 113 | Rickets (HP:0002748) | 1.93948267 |
| 114 | Abnormality of the nasal septum (HP:0000419) | 1.90068462 |
| 115 | Abnormality of iron homeostasis (HP:0011031) | 1.89863986 |
| 116 | Polyuria (HP:0000103) | 1.88996792 |
| 117 | Exercise-induced muscle cramps (HP:0003710) | 1.88727862 |
| 118 | Abnormal cartilage morphology (HP:0002763) | 1.88556971 |
| 119 | Congenital stationary night blindness (HP:0007642) | 1.88471776 |
| 120 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.87349799 |
| 121 | Hypophosphatemic rickets (HP:0004912) | 1.86883126 |
| 122 | Renal cortical cysts (HP:0000803) | 1.86351396 |
| 123 | Reduced antithrombin III activity (HP:0001976) | 1.84158585 |
| 124 | Abnormality of proline metabolism (HP:0010907) | 1.82840754 |
| 125 | Hydroxyprolinuria (HP:0003080) | 1.82840754 |
| 126 | Tubular atrophy (HP:0000092) | 1.82671047 |
| 127 | Elevated hepatic transaminases (HP:0002910) | 1.81965384 |
| 128 | Alkalosis (HP:0001948) | 1.81643540 |
| 129 | Exercise-induced myalgia (HP:0003738) | 1.81490187 |
| 130 | Status epilepticus (HP:0002133) | 1.81403015 |
| 131 | Proximal tubulopathy (HP:0000114) | 1.80815932 |
| 132 | Rhabdomyolysis (HP:0003201) | 1.79846613 |
| 133 | Hypokalemia (HP:0002900) | 1.78759834 |
| 134 | Increased circulating renin level (HP:0000848) | 1.78351053 |
| 135 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.77727132 |
| 136 | Abnormality of vitamin metabolism (HP:0100508) | 1.76797259 |
| 137 | Type II lissencephaly (HP:0007260) | 1.76340314 |
| 138 | Glycosuria (HP:0003076) | 1.74050769 |
| 139 | Abnormality of urine glucose concentration (HP:0011016) | 1.74050769 |
| 140 | Azoospermia (HP:0000027) | 1.73052589 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.52765678 |
| 2 | WNK4 | 4.86189224 |
| 3 | FGFR4 | 4.67527200 |
| 4 | SIK1 | 4.51373523 |
| 5 | ERN1 | 4.39056888 |
| 6 | OBSCN | 4.22587053 |
| 7 | TAOK3 | 3.10894156 |
| 8 | TLK1 | 2.92450746 |
| 9 | INSRR | 2.82737838 |
| 10 | ZAK | 2.82315779 |
| 11 | ERBB4 | 2.81710688 |
| 12 | STK39 | 2.75683335 |
| 13 | ADRBK2 | 2.75396061 |
| 14 | OXSR1 | 2.58535603 |
| 15 | PIK3CA | 2.54856524 |
| 16 | PHKG2 | 2.48045610 |
| 17 | PHKG1 | 2.48045610 |
| 18 | WNK3 | 2.42496610 |
| 19 | ACVR1B | 2.37687548 |
| 20 | BMPR1B | 2.36789023 |
| 21 | MAP2K4 | 2.33678706 |
| 22 | PKN2 | 2.29146407 |
| 23 | MST1R | 2.24851109 |
| 24 | TXK | 1.96534095 |
| 25 | MAPKAPK3 | 1.93354478 |
| 26 | FLT3 | 1.92058430 |
| 27 | MAPK11 | 1.88453335 |
| 28 | PIK3CG | 1.87336157 |
| 29 | TRIB3 | 1.79213623 |
| 30 | TYK2 | 1.65906135 |
| 31 | LATS1 | 1.62322079 |
| 32 | DAPK2 | 1.54318775 |
| 33 | ABL2 | 1.52019154 |
| 34 | PTK6 | 1.46388880 |
| 35 | NEK9 | 1.43274865 |
| 36 | FRK | 1.35684941 |
| 37 | KDR | 1.28112353 |
| 38 | FGFR2 | 1.26876583 |
| 39 | NUAK1 | 1.24365581 |
| 40 | NLK | 1.22351272 |
| 41 | JAK2 | 1.19767835 |
| 42 | PINK1 | 1.16524704 |
| 43 | STK38L | 1.16003787 |
| 44 | MAP4K2 | 1.14823809 |
| 45 | VRK1 | 1.13426999 |
| 46 | PRKAA2 | 1.12052857 |
| 47 | MAP3K7 | 1.10571062 |
| 48 | GRK6 | 1.08758082 |
| 49 | MAP2K3 | 1.06856101 |
| 50 | ERBB2 | 1.03583880 |
| 51 | TBK1 | 1.02450109 |
| 52 | ITK | 1.02241841 |
| 53 | TYRO3 | 0.98825317 |
| 54 | MAPK4 | 0.98689525 |
| 55 | MAP3K10 | 0.97653004 |
| 56 | MAP3K11 | 0.96809743 |
| 57 | PRKCZ | 0.94320647 |
| 58 | JAK1 | 0.93898539 |
| 59 | SIK2 | 0.93522254 |
| 60 | IRAK3 | 0.88571607 |
| 61 | MAP3K3 | 0.88528093 |
| 62 | MAP2K6 | 0.86410581 |
| 63 | CDK6 | 0.85962502 |
| 64 | MAPK15 | 0.85765574 |
| 65 | MAP3K14 | 0.85576868 |
| 66 | WNK1 | 0.85504627 |
| 67 | MET | 0.85434151 |
| 68 | NME1 | 0.85152065 |
| 69 | MUSK | 0.82078723 |
| 70 | MAP4K1 | 0.81419260 |
| 71 | CAMKK2 | 0.78955436 |
| 72 | MAP3K4 | 0.78540159 |
| 73 | TIE1 | 0.77498764 |
| 74 | NEK1 | 0.77084867 |
| 75 | MAPK12 | 0.76202642 |
| 76 | PRKACG | 0.75912543 |
| 77 | CAMK2G | 0.72454042 |
| 78 | EPHB1 | 0.70263804 |
| 79 | PRKAA1 | 0.66514071 |
| 80 | GSK3A | 0.66450731 |
| 81 | EEF2K | 0.66388939 |
| 82 | CSK | 0.66204138 |
| 83 | DYRK1B | 0.65151713 |
| 84 | EPHA3 | 0.63568781 |
| 85 | MAPK13 | 0.62864237 |
| 86 | PBK | 0.62343455 |
| 87 | IKBKB | 0.62125117 |
| 88 | RPS6KB1 | 0.58185884 |
| 89 | SGK3 | 0.57481770 |
| 90 | STK16 | 0.54450745 |
| 91 | RIPK1 | 0.54148357 |
| 92 | TRPM7 | 0.54053669 |
| 93 | PTK2 | 0.54022029 |
| 94 | MAPK7 | 0.53759891 |
| 95 | CSNK1G1 | 0.52719443 |
| 96 | CAMK1D | 0.52226955 |
| 97 | PDPK1 | 0.51725412 |
| 98 | FGFR1 | 0.51302445 |
| 99 | PRKACA | 0.50884113 |
| 100 | IKBKE | 0.50102139 |
| 101 | PRKCQ | 0.49949169 |
| 102 | TGFBR2 | 0.49614853 |
| 103 | GRK1 | 0.49507346 |
| 104 | CDK8 | 0.49377619 |
| 105 | SGK1 | 0.49360804 |
| 106 | CDK4 | 0.49121880 |
| 107 | CSF1R | 0.48714500 |
| 108 | TSSK6 | 0.47970241 |
| 109 | TAOK2 | 0.47586722 |
| 110 | EPHA4 | 0.47036127 |
| 111 | FGFR3 | 0.44900661 |
| 112 | ADRBK1 | 0.44846252 |
| 113 | MAP3K5 | 0.44086836 |
| 114 | CSNK1A1 | 0.41794491 |
| 115 | PRKCG | 0.41669404 |
| 116 | EIF2AK3 | 0.41049176 |
| 117 | NTRK3 | 0.41047265 |
| 118 | CHUK | 0.40858297 |
| 119 | BRSK2 | 0.40757243 |
| 120 | MAP2K1 | 0.40394418 |
| 121 | PRKCE | 0.40393897 |
| 122 | PRKG1 | 0.40381744 |
| 123 | SGK2 | 0.40158253 |
| 124 | IGF1R | 0.39612890 |
| 125 | VRK2 | 0.39535638 |
| 126 | PRKCI | 0.39112245 |
| 127 | RPS6KB2 | 0.38450372 |
| 128 | MAPKAPK5 | 0.38047299 |
| 129 | TEC | 0.37908799 |
| 130 | SYK | 0.37331517 |
| 131 | CSNK1D | 0.36196841 |
| 132 | RPS6KA5 | 0.36121151 |
| 133 | ICK | 0.34357070 |
| 134 | MAP3K13 | 0.33556695 |
| 135 | RET | 0.33517693 |
| 136 | MTOR | 0.33271597 |
| 137 | LCK | 0.32504864 |
| 138 | CSNK1E | 0.31773983 |
| 139 | CAMK4 | 0.30939991 |
| 140 | LATS2 | 0.30661935 |
| 141 | MAP2K2 | 0.30212704 |
| 142 | PDK1 | 0.29998895 |
| 143 | MAP3K6 | 0.29904876 |
| 144 | CSNK1G2 | 0.29519429 |
| 145 | PKN1 | 0.29313454 |
| 146 | CSNK1G3 | 0.29106557 |
| 147 | EGFR | 0.28187522 |
| 148 | PDK3 | 0.27883538 |
| 149 | PDK4 | 0.27883538 |
| 150 | SGK223 | 0.27829894 |
| 151 | SGK494 | 0.27829894 |
| 152 | CASK | 0.26864936 |
| 153 | PRKCA | 0.26443705 |
| 154 | IRAK2 | 0.25795186 |
| 155 | MAP3K1 | 0.23752923 |
| 156 | AKT3 | 0.23306594 |
| 157 | IRAK1 | 0.22046492 |
| 158 | CSNK1A1L | 0.19067245 |
| 159 | ABL1 | 0.17347817 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.50270298 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.56302743 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.37993882 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.37552810 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.09723003 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.71225542 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.68699836 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.68685697 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.67503685 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.58564403 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.49946872 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.40565998 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.27373719 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.16815290 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.12590023 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.07209294 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.94104521 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.92795721 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.92764385 |
| 20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.92414928 |
| 21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.91861765 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.84901377 |
| 23 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.80017634 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.79773806 |
| 25 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.75615987 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.72808078 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.71221595 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.71057291 |
| 29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.68028187 |
| 30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.66778098 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.63973161 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.59105187 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.55698761 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.53928505 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.52400589 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.48193004 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.44427425 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.37253152 |
| 39 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.35908812 |
| 40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.35479138 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.33684914 |
| 42 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.27013775 |
| 43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.25399296 |
| 44 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.22441205 |
| 45 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.18777238 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 1.17052354 |
| 47 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.16504733 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.14198905 |
| 49 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.05300366 |
| 50 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.03927731 |
| 51 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.03018661 |
| 52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.01668834 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.00109649 |
| 54 | Sulfur relay system_Homo sapiens_hsa04122 | 0.97441567 |
| 55 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.89223797 |
| 56 | * Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.86502130 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.86175504 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.83728322 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.81173989 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.80011201 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69851095 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67844746 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.66106146 |
| 64 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.66068921 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.60324441 |
| 66 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.55606130 |
| 67 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.49266455 |
| 68 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.47853936 |
| 69 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.47416764 |
| 70 | Mineral absorption_Homo sapiens_hsa04978 | 0.44886173 |
| 71 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.40113520 |
| 72 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.35701022 |
| 73 | Phototransduction_Homo sapiens_hsa04744 | 0.35467964 |
| 74 | Prion diseases_Homo sapiens_hsa05020 | 0.32918003 |
| 75 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.29175598 |
| 76 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26589503 |
| 77 | Galactose metabolism_Homo sapiens_hsa00052 | 0.26179751 |
| 78 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.26146147 |
| 79 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.23790171 |
| 80 | Circadian rhythm_Homo sapiens_hsa04710 | 0.22884607 |
| 81 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.20649345 |
| 82 | Insulin resistance_Homo sapiens_hsa04931 | 0.20621980 |
| 83 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.20320743 |
| 84 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.18675064 |
| 85 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.18551850 |
| 86 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17127470 |
| 87 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.14448382 |
| 88 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.07237840 |
| 89 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.07069554 |
| 90 | RNA polymerase_Homo sapiens_hsa03020 | 0.05261148 |
| 91 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.03718519 |
| 92 | Allograft rejection_Homo sapiens_hsa05330 | 0.03170553 |
| 93 | Asthma_Homo sapiens_hsa05310 | 0.02972371 |
| 94 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.00811018 |
| 95 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.00693003 |
| 96 | Bladder cancer_Homo sapiens_hsa05219 | -0.2535453 |
| 97 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2496190 |
| 98 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2465776 |
| 99 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2396848 |
| 100 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2194560 |
| 101 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2108676 |
| 102 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.2102081 |
| 103 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1981347 |
| 104 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1893148 |
| 105 | Hepatitis C_Homo sapiens_hsa05160 | -0.1809576 |
| 106 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1783667 |
| 107 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1688378 |
| 108 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1526466 |
| 109 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1519164 |
| 110 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1424675 |
| 111 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1203043 |
| 112 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1155548 |
| 113 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1134047 |
| 114 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0870408 |
| 115 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0465584 |

